FDA Panel Urges More Studies of Stroke Med A US advisory panel on Friday recommended against approving AstraZeneca #39;s new stroke prevention medication, Exanta, citing concerns about the drug #39;s effect on the liver. 
Is this a piece of news regarding world politics, sports, business, or science and technology? 